nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—liver cancer	0.441	1	CbGaD
Pethidine—CYP2B6—Sorafenib—liver cancer	0.0781	0.285	CbGbCtD
Pethidine—CYP2C19—Sorafenib—liver cancer	0.0496	0.181	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—liver cancer	0.0474	0.173	CbGbCtD
Pethidine—CYP2D6—Sorafenib—liver cancer	0.0377	0.138	CbGbCtD
Pethidine—CYP3A4—Sorafenib—liver cancer	0.024	0.0875	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—liver cancer	0.0229	0.0835	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—liver cancer	0.0146	0.0531	CbGbCtD
Pethidine—Anuria—Epirubicin—liver cancer	0.00194	0.035	CcSEcCtD
Pethidine—Anuria—Doxorubicin—liver cancer	0.00179	0.0324	CcSEcCtD
Pethidine—Neurotoxicity—Epirubicin—liver cancer	0.00175	0.0316	CcSEcCtD
Pethidine—Neurotoxicity—Doxorubicin—liver cancer	0.00162	0.0292	CcSEcCtD
Pethidine—Mood swings—Sorafenib—liver cancer	0.00126	0.0228	CcSEcCtD
Pethidine—Paralysis—Epirubicin—liver cancer	0.000974	0.0176	CcSEcCtD
Pethidine—Paralysis—Doxorubicin—liver cancer	0.000902	0.0163	CcSEcCtD
Pethidine—Flushing—Sorafenib—liver cancer	0.000854	0.0154	CcSEcCtD
Pethidine—Injection site pain—Epirubicin—liver cancer	0.000829	0.015	CcSEcCtD
Pethidine—Erythema—Sorafenib—liver cancer	0.000801	0.0145	CcSEcCtD
Pethidine—Delirium—Epirubicin—liver cancer	0.000787	0.0142	CcSEcCtD
Pethidine—Vasodilation—Epirubicin—liver cancer	0.00077	0.0139	CcSEcCtD
Pethidine—Vasodilation procedure—Epirubicin—liver cancer	0.00077	0.0139	CcSEcCtD
Pethidine—Muscle spasms—Sorafenib—liver cancer	0.00077	0.0139	CcSEcCtD
Pethidine—Injection site pain—Doxorubicin—liver cancer	0.000767	0.0139	CcSEcCtD
Pethidine—Delirium—Doxorubicin—liver cancer	0.000728	0.0132	CcSEcCtD
Pethidine—Dyskinesia—Epirubicin—liver cancer	0.00072	0.013	CcSEcCtD
Pethidine—Syncope—Sorafenib—liver cancer	0.000718	0.013	CcSEcCtD
Pethidine—Vasodilation—Doxorubicin—liver cancer	0.000713	0.0129	CcSEcCtD
Pethidine—Vasodilation procedure—Doxorubicin—liver cancer	0.000713	0.0129	CcSEcCtD
Pethidine—Loss of consciousness—Sorafenib—liver cancer	0.000704	0.0127	CcSEcCtD
Pethidine—Hypertension—Sorafenib—liver cancer	0.000691	0.0125	CcSEcCtD
Pethidine—Coordination abnormal—Epirubicin—liver cancer	0.000689	0.0125	CcSEcCtD
Pethidine—Dry mouth—Sorafenib—liver cancer	0.000667	0.0121	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—liver cancer	0.000667	0.0121	CcSEcCtD
Pethidine—Anaphylactic shock—Sorafenib—liver cancer	0.000654	0.0118	CcSEcCtD
Pethidine—Shock—Sorafenib—liver cancer	0.000643	0.0116	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—liver cancer	0.000638	0.0115	CcSEcCtD
Pethidine—Anorexia—Sorafenib—liver cancer	0.000623	0.0113	CcSEcCtD
Pethidine—Coma—Epirubicin—liver cancer	0.000619	0.0112	CcSEcCtD
Pethidine—Coma—Doxorubicin—liver cancer	0.000572	0.0104	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—liver cancer	0.00057	0.0103	CcSEcCtD
Pethidine—Decreased appetite—Sorafenib—liver cancer	0.000568	0.0103	CcSEcCtD
Pethidine—Constipation—Sorafenib—liver cancer	0.000559	0.0101	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—liver cancer	0.000528	0.00955	CcSEcCtD
Pethidine—Urticaria—Sorafenib—liver cancer	0.000519	0.00939	CcSEcCtD
Pethidine—Affect lability—Epirubicin—liver cancer	0.000484	0.00875	CcSEcCtD
Pethidine—Hypersensitivity—Sorafenib—liver cancer	0.000482	0.00871	CcSEcCtD
Pethidine—Asthenia—Sorafenib—liver cancer	0.000469	0.00848	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—liver cancer	0.000467	0.00845	CcSEcCtD
Pethidine—Mood swings—Epirubicin—liver cancer	0.000466	0.00842	CcSEcCtD
Pethidine—Pruritus—Sorafenib—liver cancer	0.000462	0.00836	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—liver cancer	0.000449	0.00812	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—liver cancer	0.000448	0.0081	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—liver cancer	0.000432	0.00782	CcSEcCtD
Pethidine—Dizziness—Sorafenib—liver cancer	0.000432	0.00782	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—liver cancer	0.000431	0.00779	CcSEcCtD
Pethidine—Vomiting—Sorafenib—liver cancer	0.000416	0.00752	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000415	0.00751	CcSEcCtD
Pethidine—Rash—Sorafenib—liver cancer	0.000412	0.00745	CcSEcCtD
Pethidine—Dermatitis—Sorafenib—liver cancer	0.000412	0.00745	CcSEcCtD
Pethidine—Headache—Sorafenib—liver cancer	0.000409	0.00741	CcSEcCtD
Pethidine—Nausea—Sorafenib—liver cancer	0.000388	0.00702	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—liver cancer	0.000379	0.00685	CcSEcCtD
Pethidine—Sweating—Epirubicin—liver cancer	0.000363	0.00657	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—liver cancer	0.00035	0.00634	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—liver cancer	0.000346	0.00626	CcSEcCtD
Pethidine—Sweating—Doxorubicin—liver cancer	0.000336	0.00608	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—liver cancer	0.000328	0.00593	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—liver cancer	0.00032	0.00579	CcSEcCtD
Pethidine—Flushing—Epirubicin—liver cancer	0.000316	0.00571	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—liver cancer	0.000303	0.00548	CcSEcCtD
Pethidine—Erythema—Epirubicin—liver cancer	0.000296	0.00535	CcSEcCtD
Pethidine—Flushing—Doxorubicin—liver cancer	0.000292	0.00528	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—liver cancer	0.000285	0.00515	CcSEcCtD
Pethidine—Erythema—Doxorubicin—liver cancer	0.000274	0.00495	CcSEcCtD
Pethidine—Agitation—Epirubicin—liver cancer	0.000272	0.00492	CcSEcCtD
Pethidine—Vertigo—Epirubicin—liver cancer	0.000266	0.00481	CcSEcCtD
Pethidine—Syncope—Epirubicin—liver cancer	0.000265	0.0048	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—liver cancer	0.000263	0.00476	CcSEcCtD
Pethidine—Palpitations—Epirubicin—liver cancer	0.000262	0.00473	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—liver cancer	0.00026	0.0047	CcSEcCtD
Pethidine—Convulsion—Epirubicin—liver cancer	0.000256	0.00464	CcSEcCtD
Pethidine—Hypertension—Epirubicin—liver cancer	0.000256	0.00462	CcSEcCtD
Pethidine—Agitation—Doxorubicin—liver cancer	0.000252	0.00455	CcSEcCtD
Pethidine—Anxiety—Epirubicin—liver cancer	0.000251	0.00454	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—liver cancer	0.000246	0.00446	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—liver cancer	0.000246	0.00445	CcSEcCtD
Pethidine—Syncope—Doxorubicin—liver cancer	0.000246	0.00444	CcSEcCtD
Pethidine—Confusional state—Epirubicin—liver cancer	0.000244	0.00441	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—liver cancer	0.000242	0.00438	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—liver cancer	0.000242	0.00437	CcSEcCtD
Pethidine—Oedema—Epirubicin—liver cancer	0.000242	0.00437	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—liver cancer	0.000241	0.00435	CcSEcCtD
Pethidine—Shock—Epirubicin—liver cancer	0.000238	0.0043	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—liver cancer	0.000237	0.00429	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—liver cancer	0.000236	0.00428	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—liver cancer	0.000236	0.00426	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—liver cancer	0.000234	0.00422	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—liver cancer	0.000232	0.0042	CcSEcCtD
Pethidine—Anorexia—Epirubicin—liver cancer	0.00023	0.00416	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—liver cancer	0.000228	0.00412	CcSEcCtD
Pethidine—Hypotension—Epirubicin—liver cancer	0.000226	0.00408	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—liver cancer	0.000225	0.00408	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—liver cancer	0.000223	0.00404	CcSEcCtD
Pethidine—Oedema—Doxorubicin—liver cancer	0.000223	0.00404	CcSEcCtD
Pethidine—Shock—Doxorubicin—liver cancer	0.00022	0.00398	CcSEcCtD
Pethidine—Insomnia—Epirubicin—liver cancer	0.000218	0.00395	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—liver cancer	0.000218	0.00395	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—liver cancer	0.000216	0.00391	CcSEcCtD
Pethidine—Somnolence—Epirubicin—liver cancer	0.000215	0.00388	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—liver cancer	0.000213	0.00385	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—liver cancer	0.00021	0.0038	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—liver cancer	0.000209	0.00378	CcSEcCtD
Pethidine—Constipation—Epirubicin—liver cancer	0.000207	0.00374	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—liver cancer	0.000202	0.00366	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—liver cancer	0.000199	0.0036	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—liver cancer	0.000199	0.00359	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—liver cancer	0.000194	0.00351	CcSEcCtD
Pethidine—Urticaria—Epirubicin—liver cancer	0.000192	0.00347	CcSEcCtD
Pethidine—Constipation—Doxorubicin—liver cancer	0.000191	0.00346	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—liver cancer	0.000184	0.00333	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—liver cancer	0.000178	0.00322	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—liver cancer	0.000178	0.00321	CcSEcCtD
Pethidine—Asthenia—Epirubicin—liver cancer	0.000173	0.00313	CcSEcCtD
Pethidine—Pruritus—Epirubicin—liver cancer	0.000171	0.00309	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—liver cancer	0.000165	0.00298	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—liver cancer	0.00016	0.0029	CcSEcCtD
Pethidine—Dizziness—Epirubicin—liver cancer	0.00016	0.00289	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—liver cancer	0.000158	0.00286	CcSEcCtD
Pethidine—Vomiting—Epirubicin—liver cancer	0.000154	0.00278	CcSEcCtD
Pethidine—Rash—Epirubicin—liver cancer	0.000152	0.00275	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—liver cancer	0.000152	0.00275	CcSEcCtD
Pethidine—Headache—Epirubicin—liver cancer	0.000151	0.00274	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—liver cancer	0.000148	0.00267	CcSEcCtD
Pethidine—Nausea—Epirubicin—liver cancer	0.000143	0.0026	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—liver cancer	0.000142	0.00257	CcSEcCtD
Pethidine—Rash—Doxorubicin—liver cancer	0.000141	0.00255	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—liver cancer	0.000141	0.00255	CcSEcCtD
Pethidine—Headache—Doxorubicin—liver cancer	0.00014	0.00253	CcSEcCtD
Pethidine—Nausea—Doxorubicin—liver cancer	0.000133	0.0024	CcSEcCtD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.1e-05	0.000135	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTA2—liver cancer	3.09e-05	0.000134	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CD—liver cancer	3.08e-05	0.000134	CbGpPWpGaD
Pethidine—ALB—Metabolism—CRABP1—liver cancer	3.01e-05	0.000131	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	3e-05	0.000131	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTA1—liver cancer	2.98e-05	0.00013	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CG—liver cancer	2.97e-05	0.000129	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CSF2—liver cancer	2.97e-05	0.000129	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—RAF1—liver cancer	2.96e-05	0.000129	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NAT2—liver cancer	2.95e-05	0.000128	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—H2AFX—liver cancer	2.92e-05	0.000127	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—IL2—liver cancer	2.92e-05	0.000127	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTA4—liver cancer	2.92e-05	0.000127	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CB—liver cancer	2.89e-05	0.000126	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTA2—liver cancer	2.84e-05	0.000124	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.84e-05	0.000123	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PRKCE—liver cancer	2.83e-05	0.000123	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALDOB—liver cancer	2.83e-05	0.000123	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	2.8e-05	0.000122	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PSMA4—liver cancer	2.78e-05	0.000121	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PSMD10—liver cancer	2.78e-05	0.000121	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTA1—liver cancer	2.74e-05	0.000119	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NAT2—liver cancer	2.71e-05	0.000118	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.71e-05	0.000118	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GOT2—liver cancer	2.71e-05	0.000118	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CRABP1—liver cancer	2.7e-05	0.000117	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.69e-05	0.000117	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	2.69e-05	0.000117	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF2—liver cancer	2.68e-05	0.000117	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL2—liver cancer	2.65e-05	0.000115	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TERT—liver cancer	2.64e-05	0.000115	CbGpPWpGaD
Pethidine—ALB—Metabolism—HPGDS—liver cancer	2.63e-05	0.000114	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CD—liver cancer	2.61e-05	0.000114	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.61e-05	0.000114	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALDOB—liver cancer	2.6e-05	0.000113	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SERPINE1—liver cancer	2.58e-05	0.000112	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP2E1—liver cancer	2.54e-05	0.000111	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CSF2—liver cancer	2.51e-05	0.000109	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—RAF1—liver cancer	2.5e-05	0.000109	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CRABP1—liver cancer	2.48e-05	0.000108	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—H2AFX—liver cancer	2.47e-05	0.000107	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—IL2—liver cancer	2.47e-05	0.000107	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	2.44e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.43e-05	0.000106	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KDR—liver cancer	2.42e-05	0.000105	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK14—liver cancer	2.4e-05	0.000104	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYCS—liver cancer	2.38e-05	0.000103	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.38e-05	0.000103	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HPGDS—liver cancer	2.36e-05	0.000103	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ESR1—liver cancer	2.36e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.34e-05	0.000102	CbGpPWpGaD
Pethidine—ALB—Metabolism—PSMD10—liver cancer	2.34e-05	0.000102	CbGpPWpGaD
Pethidine—ALB—Metabolism—PSMA4—liver cancer	2.34e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GGT1—liver cancer	2.34e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GOT1—liver cancer	2.34e-05	0.000102	CbGpPWpGaD
Pethidine—ALB—Hemostasis—RAF1—liver cancer	2.33e-05	0.000101	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—F2—liver cancer	2.33e-05	0.000101	CbGpPWpGaD
Pethidine—ALB—Metabolism—GOT2—liver cancer	2.28e-05	9.9e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CB—liver cancer	2.28e-05	9.9e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2—liver cancer	2.24e-05	9.75e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TERT—liver cancer	2.23e-05	9.71e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APC—liver cancer	2.23e-05	9.68e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CG—liver cancer	2.23e-05	9.68e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CPT1B—liver cancer	2.2e-05	9.57e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GLUL—liver cancer	2.2e-05	9.57e-05	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	2.2e-05	9.57e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HPGDS—liver cancer	2.17e-05	9.43e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP2E1—liver cancer	2.14e-05	9.31e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.14e-05	9.28e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NR1H4—liver cancer	2.12e-05	9.23e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.11e-05	9.17e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PSMA4—liver cancer	2.1e-05	9.14e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PSMD10—liver cancer	2.1e-05	9.14e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—liver cancer	2.1e-05	9.12e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—BRAF—liver cancer	2.09e-05	9.1e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—liver cancer	2.09e-05	9.09e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA3—liver cancer	2.09e-05	9.07e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.07e-05	9.01e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HMOX1—liver cancer	2.07e-05	9e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GOT2—liver cancer	2.04e-05	8.89e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KDR—liver cancer	2.04e-05	8.88e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK14—liver cancer	2.03e-05	8.82e-05	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	2.02e-05	8.78e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYCS—liver cancer	2e-05	8.71e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ESR1—liver cancer	1.99e-05	8.66e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—F2—liver cancer	1.97e-05	8.55e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GGT1—liver cancer	1.97e-05	8.55e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GOT1—liver cancer	1.97e-05	8.55e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CD—liver cancer	1.96e-05	8.51e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	1.94e-05	8.43e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SERPINE1—liver cancer	1.94e-05	8.42e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PSMD10—liver cancer	1.93e-05	8.41e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PSMA4—liver cancer	1.93e-05	8.41e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—liver cancer	1.93e-05	8.38e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP2E1—liver cancer	1.92e-05	8.36e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—liver cancer	1.92e-05	8.33e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA4—liver cancer	1.91e-05	8.3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APC—liver cancer	1.88e-05	8.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—liver cancer	1.88e-05	8.18e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GOT2—liver cancer	1.88e-05	8.18e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.86e-05	8.09e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA2—liver cancer	1.86e-05	8.08e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1A1—liver cancer	1.83e-05	7.95e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYCS—liver cancer	1.8e-05	7.82e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA1—liver cancer	1.79e-05	7.8e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—liver cancer	1.78e-05	7.73e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NAT2—liver cancer	1.77e-05	7.71e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BRAF—liver cancer	1.77e-05	7.69e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2E1—liver cancer	1.77e-05	7.69e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—liver cancer	1.77e-05	7.68e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GGT1—liver cancer	1.76e-05	7.67e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GOT1—liver cancer	1.76e-05	7.67e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	1.76e-05	7.66e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RAF1—liver cancer	1.75e-05	7.6e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—HMOX1—liver cancer	1.74e-05	7.57e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MTOR—liver cancer	1.71e-05	7.42e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—liver cancer	1.71e-05	7.42e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—liver cancer	1.7e-05	7.41e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALDOB—liver cancer	1.7e-05	7.39e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARA—liver cancer	1.67e-05	7.27e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—liver cancer	1.65e-05	7.19e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYCS—liver cancer	1.65e-05	7.19e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.64e-05	7.13e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SERPINE1—liver cancer	1.64e-05	7.11e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB1—liver cancer	1.63e-05	7.09e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—liver cancer	1.63e-05	7.08e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GOT1—liver cancer	1.62e-05	7.06e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GGT1—liver cancer	1.62e-05	7.06e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—liver cancer	1.62e-05	7.06e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CRABP1—liver cancer	1.62e-05	7.05e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—liver cancer	1.62e-05	7.04e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1B—liver cancer	1.6e-05	6.96e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—liver cancer	1.59e-05	6.89e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—liver cancer	1.58e-05	6.89e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—liver cancer	1.57e-05	6.82e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—liver cancer	1.57e-05	6.81e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HMOX1—liver cancer	1.56e-05	6.8e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—liver cancer	1.56e-05	6.78e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1A1—liver cancer	1.54e-05	6.69e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—liver cancer	1.53e-05	6.64e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JUN—liver cancer	1.52e-05	6.63e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—liver cancer	1.51e-05	6.58e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—liver cancer	1.51e-05	6.57e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	1.49e-05	6.47e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—liver cancer	1.48e-05	6.45e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1A—liver cancer	1.48e-05	6.43e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RAF1—liver cancer	1.48e-05	6.42e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—liver cancer	1.46e-05	6.34e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—liver cancer	1.46e-05	6.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK8—liver cancer	1.44e-05	6.27e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MTOR—liver cancer	1.44e-05	6.27e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—liver cancer	1.44e-05	6.27e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—liver cancer	1.44e-05	6.25e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HMOX1—liver cancer	1.44e-05	6.25e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—liver cancer	1.43e-05	6.24e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—liver cancer	1.43e-05	6.22e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HPGDS—liver cancer	1.42e-05	6.17e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARA—liver cancer	1.41e-05	6.12e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—liver cancer	1.39e-05	6.04e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—liver cancer	1.38e-05	6.01e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1A1—liver cancer	1.38e-05	6e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—liver cancer	1.38e-05	5.99e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1B—liver cancer	1.35e-05	5.88e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—liver cancer	1.34e-05	5.84e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—liver cancer	1.34e-05	5.83e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—liver cancer	1.34e-05	5.82e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—liver cancer	1.33e-05	5.79e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—liver cancer	1.33e-05	5.77e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—liver cancer	1.32e-05	5.76e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—liver cancer	1.32e-05	5.73e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—liver cancer	1.32e-05	5.73e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—liver cancer	1.29e-05	5.61e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JUN—liver cancer	1.29e-05	5.6e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—liver cancer	1.29e-05	5.6e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—liver cancer	1.28e-05	5.58e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—liver cancer	1.28e-05	5.56e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.27e-05	5.52e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.26e-05	5.5e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PSMA4—liver cancer	1.26e-05	5.5e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PSMD10—liver cancer	1.26e-05	5.5e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARA—liver cancer	1.26e-05	5.49e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—liver cancer	1.26e-05	5.47e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—liver cancer	1.25e-05	5.45e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1A—liver cancer	1.25e-05	5.43e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—liver cancer	1.24e-05	5.4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GOT2—liver cancer	1.23e-05	5.35e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—liver cancer	1.23e-05	5.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TGFB1—liver cancer	1.22e-05	5.31e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK8—liver cancer	1.22e-05	5.3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—liver cancer	1.22e-05	5.29e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—liver cancer	1.21e-05	5.24e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—liver cancer	1.18e-05	5.15e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—liver cancer	1.16e-05	5.06e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARA—liver cancer	1.16e-05	5.05e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.16e-05	5.03e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.13e-05	4.93e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—liver cancer	1.13e-05	4.93e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—liver cancer	1.13e-05	4.92e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—liver cancer	1.13e-05	4.89e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—liver cancer	1.11e-05	4.85e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—liver cancer	1.1e-05	4.77e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—liver cancer	1.08e-05	4.7e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYCS—liver cancer	1.08e-05	4.7e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GGT1—liver cancer	1.06e-05	4.61e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GOT1—liver cancer	1.06e-05	4.61e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—liver cancer	1.06e-05	4.61e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—liver cancer	1.04e-05	4.54e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—liver cancer	1.04e-05	4.52e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—liver cancer	1.04e-05	4.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TGFB1—liver cancer	1.03e-05	4.49e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—liver cancer	1.01e-05	4.38e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—liver cancer	9.95e-06	4.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—liver cancer	9.62e-06	4.18e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—liver cancer	9.6e-06	4.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—liver cancer	9.57e-06	4.16e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—liver cancer	9.53e-06	4.15e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—liver cancer	9.51e-06	4.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMOX1—liver cancer	9.4e-06	4.09e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—liver cancer	9.39e-06	4.08e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—liver cancer	9.23e-06	4.01e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—liver cancer	9.21e-06	4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—liver cancer	8.79e-06	3.82e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—liver cancer	8.76e-06	3.81e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—liver cancer	8.75e-06	3.8e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—liver cancer	8.63e-06	3.75e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—liver cancer	8.5e-06	3.7e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—liver cancer	8.5e-06	3.69e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1A1—liver cancer	8.3e-06	3.61e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—liver cancer	8.29e-06	3.6e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—liver cancer	8.13e-06	3.54e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—liver cancer	7.78e-06	3.38e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—liver cancer	7.74e-06	3.37e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—liver cancer	7.62e-06	3.31e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARA—liver cancer	7.6e-06	3.3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—liver cancer	7.18e-06	3.12e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—liver cancer	6.69e-06	2.91e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—liver cancer	6.51e-06	2.83e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—liver cancer	6.28e-06	2.73e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—liver cancer	5.72e-06	2.49e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—liver cancer	5.65e-06	2.45e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—liver cancer	5.63e-06	2.45e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—liver cancer	5.46e-06	2.38e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—liver cancer	5.05e-06	2.2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—liver cancer	4.98e-06	2.17e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—liver cancer	4.65e-06	2.02e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—liver cancer	4.6e-06	2e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—liver cancer	4.13e-06	1.79e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—liver cancer	3.8e-06	1.65e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—liver cancer	3.04e-06	1.32e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—liver cancer	2.48e-06	1.08e-05	CbGpPWpGaD
